Symrise


Everything fine?

13/03/19 -"We believe Symrise is in good shape, but the business gave management some challenging tasks (e.g. raw material prices) in order to keep profitability up. Symrise’s FY figures matched our ..."

Pages
48
Language
English
Published on
13/03/19
You may also be interested by these reports :
13/06/19
For a sector supposedly a victim of trimmed world GDP growth expectations, European Chemicals are holding up their turn quite well. Over the last ...

31/05/19
Like Covestro’s local rival, BASF, the company is suffering from already-high and still-increasing MDI/TDI capacity in the market, considerably lower ...

31/05/19
Despite having a more resilient business model, Lanxess remains part of the chemicals’ family. We have written off chemicals for 2019 and at present ...

31/05/19
Due to the higher chance of a hotting up in the trade war, we have written off the chemicals sector for 2019 and at present do not see a strong ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO